X.'s Insider Trades & SAST Disclosures
X.'s most recent trade in HF Foods Group Inc. was a trade of 2,631 Common Stock done at an average price of $3.8 . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern X..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HF Foods Group Inc. | Xi Lin | President and CEO | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 14 May 2025 | 2,631 | 408,230 (0%) | 0% | 3.8 | 10,024 | Common Stock |
| CNB Financial Corp (PA) | Francis X. Straub | Director | Grant, award, or other acquisition of securities at price $ 22.83 per share. | 14 May 2025 | 1,383 | 36,169 (0%) | 0% | 22.8 | 31,574 | Common Stock |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 542,880 | 542,887 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. | 13 May 2025 | 41,760 | 41,760 (0%) | 0% | 6.5 | 271,440 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 223.41 per share. | 13 May 2025 | 21,235 | 10,304 (0%) | 0% | 223.4 | 4,744,092 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 222.83 per share. | 13 May 2025 | 10,221 | 31,539 (0%) | 0% | 222.8 | 2,277,501 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 224.32 per share. | 13 May 2025 | 10,104 | 200 (0%) | 0% | 224.3 | 2,266,542 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 225.68 per share. | 13 May 2025 | 200 | 0 (0%) | 0% | 225.7 | 45,136 | American Depositary Shares |
| Alpha & Omega Semiconducto... | Bing Xue | EVP-WW Sales & Bus Development | Sale of securities on an exchange or to another person at price $ 23.73 per share. | 12 May 2025 | 1,845 | 130,951 (0%) | 0% | 23.7 | 43,782 | Common Share |
| Cava Group Inc | Theodore Xenohristos | Director, Chief Concept Officer | Sale of securities on an exchange or to another person at price $ 94.46 per share. | 09 May 2025 | 4,954 | 357,665 | - | 94.5 | 467,955 | Common Stock |
| Cava Group Inc | Theodore Xenohristos | Director, Chief Concept Officer | Sale of securities on an exchange or to another person at price $ 95.36 per share. | 09 May 2025 | 4,394 | 353,271 | - | 95.4 | 419,012 | Common Stock |
| Coherent Corp | Howard H. Xia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 2,000 | 3,000 | - | - | Option (Right to buy) | |
| Coherent Corp | Howard H. Xia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.84 per share. | 09 May 2025 | 2,000 | 49,747 (0%) | 0% | 17.8 | 35,680 | Common Stock |
| Coherent Corp | Howard H. Xia | Director | Sale of securities on an exchange or to another person at price $ 76.84 per share. | 09 May 2025 | 1,000 | 48,747 (0%) | 0% | 76.8 | 76,840 | Common Stock |
| Coherent Corp | Howard H. Xia | Director | Sale of securities on an exchange or to another person at price $ 78.00 per share. | 09 May 2025 | 1,000 | 47,747 (0%) | 0% | 78 | 78,000 | Common Stock |
| Coherent Corp | Howard H. Xia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 1,000 | 5,000 | - | - | Option (Right to buy) | |
| Coherent Corp | Howard H. Xia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.84 per share. | 09 May 2025 | 1,000 | 48,747 (0%) | 0% | 17.8 | 17,840 | Common Stock |
| Coherent Corp | Howard H. Xia | Director | Sale of securities on an exchange or to another person at price $ 72.68 per share. | 09 May 2025 | 1,000 | 47,747 (0%) | 0% | 72.7 | 72,685 | Common Stock |
| Koppers Holdings Inc | Feng Xudong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 4,778 | 16,477 | - | - | Restricted Stock Units | |
| Autoliv Inc. | Xiaozhi Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 1,706 | 1,706 | - | - | Restricted Stock Unit | |
| Autoliv Inc. | Xiaozhi Liu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 1,261 | 15,416 (0%) | 0% | 0 | Common Stock | |
| Autoliv Inc. | Xiaozhi Liu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 1,261 | 0 | - | - | Restricted Stock Unit | |
| Autoliv Inc. | Xiaozhi Liu | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.23 per share. | 08 May 2025 | 189 | 15,227 (0%) | 0% | 95.2 | 17,998 | Common Stock |
| Sky Harbour Group Corporat... | Francisco X. Gonzalez | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.43 per share. | 07 May 2025 | 5,104 | 504,618 | - | 11.4 | 58,339 | Class A Common Stock |
| LKQ Corp | Xavier Francois Emile Urbain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 4,176 | 19,782 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Xavier Francois Emile Urbain | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.54 per share. | 07 May 2025 | 1,112 | 18,669 (0%) | 0% | 39.5 | 43,974 | Common Stock |
| Aptargroup Inc. | Julie Xing | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 1,069 | 3,765 (0%) | 0% | 0 | Common Stock | |
| Aptargroup Inc. | Xiangwei Gong | President, Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 6,677 | 19,835 (0%) | 0% | 0 | Common Stock | |
| Aptargroup Inc. | Xiangwei Gong | President, Asia | Payment of exercise price or tax liability using portion of securities received from the company at price $ 152.00 per share. | 02 May 2025 | 2,570 | 17,265 (0%) | 0% | 152 | 390,640 | Common Stock |
| Usana Health Sciences Inc | Xia Ding | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 674 | 0 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Xia Ding | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 674 | 4,713 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Xia Ding | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.44 per share. | 02 May 2025 | 169 | 4,544 (0%) | 0% | 29.4 | 4,975 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.90 per share. | 01 May 2025 | 150,000 | 51,550,367 (29%) | 0% | 16.9 | 2,534,700 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 150,000 | 434,880 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 106.24 per share. | 01 May 2025 | 120,952 | 51,391,879 (29%) | 0% | 106.2 | 12,849,432 | Common Stock |
| HF Foods Group Inc. | Xi Lin | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 101,250 | 101,250 | - | - | Performance Stock Units | |
| HF Foods Group Inc. | Xi Lin | President and CEO | Grant, award, or other acquisition of securities at price $ 3.80 per share. | 01 May 2025 | 101,250 | 405,599 (0%) | 0% | 3.8 | 384,750 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 105.64 per share. | 01 May 2025 | 37,536 | 51,512,831 (29%) | 0% | 105.6 | 3,965,367 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.21 per share. | 01 May 2025 | 8,349 | 51,400,367 (29%) | 0% | 104.2 | 870,049 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,260 | 51,404,159 (29%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,260 | 43,820 | - | - | Restricted Stock Units | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,020 | 51,397,899 (29%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,020 | 18,050 | - | - | Restricted Stock Units | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 4,557 | 51,408,716 (29%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 4,557 | 50,134 | - | - | Restricted Stock Units | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.21 per share. | 01 May 2025 | 3,490 | 11,003,614 (6%) | 0% | 104.2 | 363,693 | Common Stock |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 106.24 per share. | 01 May 2025 | 2,780 | 11,000,068 (6%) | 0% | 106.2 | 295,341 | Common Stock |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,764 | 11,004,862 (6%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,764 | 19,344 | - | - | Restricted Stock Units | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,242 | 11,007,104 (6%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,242 | 24,665 | - | - | Restricted Stock Units | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,030 | 11,002,098 (6%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,030 | 6,090 | - | - | Restricted Stock Units | |
| Fortinet Inc | Michael Xie | Director, VP, ENGINEERING & CTO | Sale of securities on an exchange or to another person at price $ 105.66 per share. | 01 May 2025 | 766 | 11,002,848 (6%) | 0% | 105.7 | 80,932 | Common Stock |
| NB Bancorp Inc. | Francis X. Orfanello | Director | Purchase of securities on an exchange or from another person at price $ 17.09 per share. | 29 Apr 2025 | 5,000 | 130,237 | - | 17.1 | 85,450 | Common Stock |
| Badger Meter Inc. | Xia Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 494 | 3,034 | - | - | Phantom Stock Units | |
| Badger Meter Inc. | Xia Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 78 | 2,540 | - | - | Phantom Stock Units | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 26 Apr 2025 | 4,353 | 374,504 (2%) | 0% | 18.9 | 82,185 | Common Stock |
| NB Bancorp Inc. | Francis X. Orfanello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 75,237 | 125,237 | - | 0 | Common Stock | |
| Nixxy Inc. | Xuqiang Adam Yang | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Textron Inc. | Michael X. Garrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 2,794 | 6,537 (0%) | 0% | 0 | Common Stock | |
| Ceribell Inc. | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 22 Apr 2025 | 15,628 | 727,151 | - | 15.1 | 236,139 | Common Stock |
| Ceribell Inc. | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 22 Apr 2025 | 300 | 742,779 | - | 15.1 | 4,518 | Common Stock |
| BeyondSpring Inc | Sihai Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 19,852 | 19,852 | - | - | Stock Options (right to buy) | |
| Ceribell Inc. | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 17 Apr 2025 | 5,700 | 746,451 | - | 15.0 | 85,614 | Common Stock |
| Ceribell Inc. | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 17 Apr 2025 | 3,372 | 743,079 | - | 15.0 | 50,681 | Common Stock |
| HF Foods Group Inc. | Xi Lin | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 30,292 | 304,349 (0%) | 0% | 0 | Common Stock | |
| STAG Industrial Inc | Francis X. Jacoby | Director | Grant, award, or other acquisition of securities at price $ 33.60 per share. | 15 Apr 2025 | 483 | 32,035 (0%) | 0% | 33.6 | 16,229 | Common Stock |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 542,880 | 1,085,767 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. | 14 Apr 2025 | 41,760 | 41,760 (0%) | 0% | 6.5 | 271,440 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 242.59 per share. | 14 Apr 2025 | 15,041 | 14,290 (0%) | 0% | 242.6 | 3,648,733 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 243.41 per share. | 14 Apr 2025 | 6,398 | 7,892 (0%) | 0% | 243.4 | 1,557,363 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 240.41 per share. | 14 Apr 2025 | 5,516 | 31,560 (0%) | 0% | 240.4 | 1,326,124 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 239.51 per share. | 14 Apr 2025 | 2,884 | 37,076 (0%) | 0% | 239.5 | 690,755 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 241.51 per share. | 14 Apr 2025 | 2,229 | 29,331 (0%) | 0% | 241.5 | 538,323 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 245.56 per share. | 14 Apr 2025 | 2,056 | 4,244 (0%) | 0% | 245.6 | 504,876 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 246.40 per share. | 14 Apr 2025 | 1,869 | 2,375 (0%) | 0% | 246.4 | 460,516 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 244.56 per share. | 14 Apr 2025 | 1,592 | 6,300 (0%) | 0% | 244.6 | 389,337 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 247.46 per share. | 14 Apr 2025 | 1,475 | 900 (0%) | 0% | 247.5 | 365,007 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 237.56 per share. | 14 Apr 2025 | 995 | 40,765 (0%) | 0% | 237.6 | 236,373 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 238.48 per share. | 14 Apr 2025 | 805 | 39,960 (0%) | 0% | 238.5 | 191,976 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 248.90 per share. | 14 Apr 2025 | 535 | 365 (0%) | 0% | 248.9 | 133,162 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Sale of securities on an exchange or to another person at price $ 249.45 per share. | 14 Apr 2025 | 365 | 0 (0%) | 0% | 249.5 | 91,050 | American Depositary Shares |
| GigaCloud Technology Inc -... | Xiaoyang Erica Wei | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 13,000 | 19,000 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| GigaCloud Technology Inc -... | Xinyan Hao | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 12,500 | 807,486 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| GigaCloud Technology Inc -... | Xinyan Hao | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 12,500 | 7,500 | - | - | Restricted Share Units | |
| GigaCloud Technology Inc -... | Xin Wan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 10,000 | 0 | - | - | Restricted Share Units | |
| GigaCloud Technology Inc -... | Xin Wan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 10,000 | 817,540 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| GigaCloud Technology Inc -... | Xinyan Hao | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 7,500 | 20,000 | - | - | Restricted Share Units | |
| GigaCloud Technology Inc -... | Xinyan Hao | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 7,500 | 794,986 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| GigaCloud Technology Inc -... | Xin Wan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 5,500 | 5,500 | - | - | Restricted Share Units | |
| GigaCloud Technology Inc -... | Xin Wan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 5,500 | 5,500 | - | 0 | Class A Ordinary Shares, par value $0.05 per share | |
| BeiGene Ltd - ADR | Xiaobin Wu | President, COO & GM China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 460,772 | 296,049 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Xiaobin Wu | President, COO & GM China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 214,201 | 0 | - | - | Share Option (Right to Buy) | |
| Ceribell Inc. | Xingjuan Chao | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 151,582 | 151,582 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc. | Xingjuan Chao | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 90,950 | 752,151 | - | 0 | Common Stock | |
| Replimune Group Inc | Konstantinos Xynos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 67,500 | 67,500 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Konstantinos Xynos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 45,000 | 154,885 (0%) | 0% | 0 | Common Stock | |
| BeiGene Ltd - ADR | Xiaobin Wu | President, COO & GM China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 174.43 per share. | 01 Apr 2025 | 35,444 | 51,921 (0%) | 0% | 174.4 | 6,182,497 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaobin Wu | President, COO & GM China | Sale of securities on an exchange or to another person at price $ 280.31 per share. | 01 Apr 2025 | 28,253 | 23,668 (0%) | 0% | 280.3 | 7,919,638 | American Depositary Shares |
| BeiGene Ltd - ADR | Xiaobin Wu | President, COO & GM China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.96 per share. | 01 Apr 2025 | 16,477 | 16,477 (0%) | 0% | 120.0 | 1,976,581 | American Depositary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges